ADIPOQ and autosomal dominant polycystic kidney disease: In conclusion, this report demonstrated that serum adiponectin levels could influence the clinical phenotype of ADPKD patients, and that to analyze the association between polymorphisms and ADPKD risk could potentially provide important insights into ameliorating kidney outcome.